
Session explores practicality of models for selling low-cost drugs.

DIA session highlights strategies for stakeholders to make clinical trials more inclusive for diverse populations.

Panel at DIA discussed the evolving role of pharmacies in clinical trials.

Sponsors offers patient and caregiver insights on hybrid and decentralized clinical trial design provided by their feedback processes.

Speakers dive into the importance of risk-based methods and central-monitoring solutions as they pertain to these trials.

What does the future of digital health look like?